San Francisco, 19 December 2018,
Primary Cell Culture Market Analysis Report By
Product, By Application (Stem Cell Therapy, Vaccine Production), By Separation
and Culture Method, By Region, And Segment Forecasts, 2018 - 2025
The global primarycell culture market size is expected to reach USD 5.4 billion
by 2025 and is expected to register a CAGR 10.6% during the forecast
period,according to a new report by Grand View Research, Inc. Growth in
production of vaccines, monoclonal antibodies, and regenerative medicines,
patent expiration of blockbuster biologics, and rising demand for stem cell
therapy and tissue engineering are factors promoting the growth of this market.
These trends are attracting big players in healthcare and medical research
toward this field.
Primary cell culture is
increasingly being used in fields such as drug screening, organogenesis,
disease diagnosis, biological product manufacturing, cancer research, and stem
cell research. Due to their increased use in various healthcare domains,
private medical organizations, pharmaceutical and biotech companies, education,
research and government organizations have increased their investments and
funding in this market.
Primary cells show high
physiological resemblance to the tissues and organs they are extracted from.
This provides immense help to researchers and scientists in understanding
various complexities related to drug pathways, studying diseases and drug
development, and their effect on biological site of action in-vivo. Due to
these qualities, their use has increased in biopharmaceuticals, transplants,
and chronic disease therapies. Their sprouting customized use for different
research purposes is also a key trend in the industry.
However, there are many ethical
concerns over the usage of human embryonic cells, which poses as a major
restraint in the growth of this market. Usage of transgenic plants and animals
and stem cells, as well as stringent rules and regulations associated with it,
will also negatively affect market growth in the years to come.
Currently, North America holds
the largest share in the market, with Asia Pacific expected to witness the
fastest growth during the forecast period. This can be attributed to rising per
capita incomes, growing healthcare affordability, and improving economic status
of countries such as India and China.
Commercial players in this
market are mostly established companies; however, several new players have been
making their presence known in recent years. Some of the key players are Merck
KGaA; Lonza; Promocell GmbH; GE Healthcare; and Corning, Inc.
Access Full Research
Report On Primary Cell Culture Market Analysis:
www.grandviewresearch.com/industry-analysis/primary-cell-culture-market
www.grandviewresearch.com/industry-analysis/primary-cell-culture-market
Further key findings from the report suggest:
·
Growing need for stem cells
transplants and increasing number of clinical research studies and medical
therapies for chronic diseases are expected to drive the market
·
Increasing prevalence of
chronic illnesses all over the world and ongoing researches in several
therapeutic areas has resulted in rapid advancements in stem cell therapy,
cancer treatment, gene therapy, and regenerative medicine
·
While media held the dominant
share by way of product, the reagents and supplements segment is expected to
register a CAGR of 10.8% during the forecast period
·
On the basis of separation and
culture technique, enzymatic disaggregation held the dominant share in 2017.
This is due to high productivity yield and less damage associated with this
technique. Enzymes widely used for carrying out degradation process include
trypsin, collagenase, and papain
·
North America holds the largest
revenue share in the market. Registering a CAGR of 12.2% during the forecast
period, Asia Pacific is poised to emerge as the fastest growing region in the
coming years
·
Lonza, Merck, Thermo Fisher,
and GE Healthineers are some of the leading players in this market. The number
of new players venturing in this space is increasing each year.
Browse More Reports Of This Category By
Grand View Research At: www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the
global primary cell culture market based on product, application, separation
and culture technique, and region:
Primary Cell Culture Product
Outlook (Revenue, USD Million, 2014 - 2025)
·
Primary Cell
o
Fat
o
Blood
o
Nerve
o
Bone
o
Endothelial
o
Skin
o
Muscle
o
Stem
o
Others
·
Reagents and Supplements
o
Attachment Solutions
o
Buffers and Salts
o
Freezing Media
o
Sera
o
Growth Factors and Cytokines
o
Others
·
Media
o
Fat Media
o
Blood Media
o
Nerve Media
o
Bone Media
o
Endothelial Media
o
Skin Media
o
Muscle Media
o
Stem Media
o
Others
Primary Cell Culture
Application Outlook (Revenue, USD Million, 2014 - 2025)
·
Tissue Culture & Tissue
Engineering
·
Vaccine Production
·
Gene Therapy and Regenerative
Medicine
·
Toxicity Testing and Drug
Screening
·
Cancer Research
·
Model System
·
Virology
·
Prenatal Diagnosis
·
Stem Cell Therapy
·
Others
Primary Cell Culture Separation
and Culture Techniques Outlook (Revenue, USD Million, 2014 - 2025)
·
Explant Method
·
Enzymatic Disaggregation
o
Trypsin
o
Collagenase
o
Protease
o
Pronase
o
Dispase
o
Hyaluronidase
o
Neuraminidase
o
Elastase
o
DNase
o
Papain
o
Accutase
o
Others
·
Mechanical Separation
·
Others
Primary Cell Culture Regional
Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
U.K.
·
Asia Pacific
o
China
o
Japan
·
Latin America
o
Brazil
o
Mexico
·
Middle East & Africa
o
South Africa
Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-primary-cell-culture-market
www.grandviewresearch.com/press-release/global-primary-cell-culture-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more information: www.grandviewresearch.com/
